Blue Trust’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.48K Sell
86
-1,390
-94% -$67.6K ﹤0.01% 1926
2026
Q2
$77.3K Buy
1,476
+1,221
+479% +$47.7K ﹤0.01% 1151
2026
Q1
$9.02K Sell
255
-682
-73% -$21.2K ﹤0.01% 1866
2025
Q4
$26.2K Sell
937
-409
-30% -$12.3K ﹤0.01% 1595
2025
Q3
$40.4K Sell
1,346
-169
-11% -$4.76K ﹤0.01% 1479
2025
Q2
$43.3K Buy
1,515
+72
+5% +$2.14K ﹤0.01% 1487
2025
Q1
$47.6K Sell
1,443
-259
-15% -$8.45K ﹤0.01% 1387
2024
Q4
$48.9K Buy
1,702
+1,629
+2,232% +$46.8K ﹤0.01% 1311
2024
Q3
$1.76K Buy
73
+49
+204% +$1.31K ﹤0.01% 2603
2024
Q2
$650 Buy
+24
New +$589 ﹤0.01% 2588

Other funds holding ALKS

Blue Trust's ALKS Position: Q3 2026 in Review

Blue Trust reduced its Alkermes (ALKS) stake by 94% in Q3 2026, selling an estimated $67.6K and leaving 86 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

Blue Trust first reported a position in ALKS in Q2 2024 and has held it in 10 quarters since. The position peaked at $77.3K in Q2 2026. 329 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Blue Trust held 86 shares of Alkermes worth $3.48K as of Q3 2026.
  • Blue Trust sold 1,390 Alkermes shares in Q3 2026, an estimated $67.6K.
  • Alkermes made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1926 holding.
  • Blue Trust first reported a position in Alkermes in Q2 2024 and has held it in 10 quarters since.
  • Blue Trust's Alkermes position peaked at $77.3K in Q2 2026.
  • 329 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.